by Committee to Elect MaryEllen Odell | Dec 28, 2017 | features, News
From The Putnam Examiner: https://www.theexaminernews.com/costco-absolutely-committed-to-patterson-crossing-site/ Costco made it clear last Monday that it’s coming to the Town of Patterson no matter what. That was the overarching message during a meeting with Putnam...
by Committee to Elect MaryEllen Odell | Dec 19, 2017 | features, Initiatives, News, Society
CARMEL, NY – Surrounded by county officials, state representatives and local community leaders, Putnam County Executive MaryEllen Odell signed the resolution directing the county government to join the New York Opioid Cost Recovery litigation, on Monday, Dec. 18 at...
by Committee to Elect MaryEllen Odell | Dec 19, 2017 | Economy, features, Initiatives, News
CARMEL, NY – Putnam County Executive MaryEllen Odell announced that the Danbury-Brewster sewer project has been awarded $1.147 million in New York State funding. The project, which extends the Danbury sewer line over the state border and through the Route 6 corridor...
by Committee to Elect MaryEllen Odell | Dec 18, 2017 | News
CARMEL, NY – Putnam County Executive MaryEllen Odell announces the reopening of the Drewville Road Bridge in Carmel. The New York State Department of Transportation has approved the reopening today, Friday, December 15, after the Putnam County Highways and Facilities...
by Committee to Elect MaryEllen Odell | Dec 10, 2017 | News
Carmel, NY – Putnam County students can apply for paid and unpaid summer internships in county government through the Putnam Invests in Leaders of Tomorrow (PILOT) Program as of Friday, Dec. 1. Now entering its fifth year, the concept of the PILOT Program was first...
by Committee to Elect MaryEllen Odell | Dec 4, 2017 | features, Initiatives, Issues, News, Society
CARMEL, NY – Determined to battle the cause of the opioid crisis in Putnam, County Executive MaryEllen Odell urged the Legislature to allow the government to join various states and counties across the country in filing lawsuits against both pharmaceutical companies...
